Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
av5080 (2 trials)
efavirenz (sustiva) (1 trial)
elsulfavirine (Elpida) (14 trials)
emtricitabine (emtriva) (2 trials)
interferon alpha-2b (Intron-A) (1 trial)
raltegravir (isentress) (2 trials)
tenofovir (viread) (2 trials)
atorvastatin (lipitor) (1 trial)
clarithromycin (biaxin) (1 trial)
daclatasvir (daklinza) (1 trial)
darunavir (prezista) (1 trial)
dolutegravir (tivicay) (1 trial)
ethinyl estradiol (Estinyl) (1 trial)
levonorgestrel (1 trial)
omeprazole (prilosec) (1 trial)
rifabutin (mycobutin) (1 trial)
rifampin (1 trial)
ritonavir (Norvir) (1 trial)
sofosbuvir (sovaldi) (1 trial)
Acquired Immunodeficiency Syndrome (Phase 2)
Communicable Diseases (Phase 2)
HIV Infections (Phase 2)
Infections (Phase 2)
Liver Diseases (Phase 1)
Trials (16 total)
Trial APIs (19 total)